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that it is only cost effective in a small 
number of cases. An alternative, general-
izable, approach could involve extensive 
displacement of the solvent by a matrix 
that remains permeable to the substrate, 
thereby immobilizing and stabilizing pro-
teins for diverse applications.
Immobilization of biocatalysts on 
solid supports has been achieved and is 
often a more desirable alternative to the 
application of free enzymes in solution. 
Immobilized enzymes can have extended 
lifespans,[7,8] greater stability to tempera-
ture extremes,[9,10] tolerate nonaqueous 
solvents,[11,12] and display enhanced reac-
tion rates.[13] Immobilized enzymes can 
also be added to and removed from reac-
tion mixtures with ease. However, enzyme 
immobilization has limitations. Covalent 
attachment, generally considered the most 
robust form of immobilization, requires covalent tethering of 
the biocatalyst to a solid support. The chemical operations in 
these processes can be costly, time consuming, and require 
additional protection steps after enzyme immobilization.[14] 
Additionally, covalent attachment often results in enzymes 
adopting unfavorable orientations on the solid media, and 
unless the site for attachment is rigorously tested and selected, 
reduced activity can result from occlusion of the active site. 
Covalent chemical attachment also complicates recycling of 
the solid support since stripping degraded enzyme from the 
support requires further chemical processing and priming for 
reapplication of new enzyme.
There are alternatives[15] to covalent tethering, including the 
generation of catalytically active inclusion bodies (CatIBs), and 
gel encapsulation. The former technique involves the immo-
bilization of precipitated, catalytically active enzyme through 
The remarkable catalytic potential of enzymes in chemical synthesis, environ-
mental bioremediation, and medical therapeutics is limited by their longevity 
and stability. Immobilization of enzymes on solid supports is demonstrated 
to improve the stability of biocatalysts but often relies on multiple chemical 
steps for covalent attachment and is limited by the physical properties of 
the various supports. Here, production of enzyme: hydrogel complexes is 
described via engineering of a cationic supercharged phosphotriesterase. 
These enzyme: hydrogel complexes are remarkably robust displaying no loss 
of catalytic activity after 80 d of use and up to 105 turnovers when used in a 
flow reactor at catalyst loadings as low as 0.0008 mol%. In addition, excep-
tional resilience to organic solvents is observed. The use of enzyme: hydrogel 
complexes is likely to be of value in a diverse range of applications such as 
enantioselective continuous-flow chemistry, detoxification of poisons, and the 
formation of functionalized biomaterials.
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Biocatalysis
The catalytic power and specificity of enzymes is well docu-
mented,[1] but their use in industry and medicine can be lim-
ited by several factors. For example, many industrial processes 
require the use of organic solvents, which can be destabilizing 
to otherwise effective biocatalysts,[2] while enzymes in solution 
have a limited lifespan due to their tendency to unfold and 
aggregate[3] and are often not reusable in modern applications, 
which increases their cost.[4] Many of these deficiencies result 
from enzymes having evolved to function in vivo, where con-
ditions are generally aqueous and of moderate temperature. 
Additionally, since they can be readily resynthesized in vivo, 
enzymes generally have relatively short lifespans in solution. 
Although there are examples where proteins have been engi-
neered to tolerate nonaqueous solvents and to display greater 
stability,[5,6] the requirement to perform engineering and 
optimization on each individual enzyme to achieve this means 
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crosslinking.[16] Recent work has shown CatIBs to be long lived 
and stable toward organic solvents,[17] but their effective utiliza-
tion requires encapsulation in alginate or agar beads,[18,19] and 
while CatIBs offer interesting functional properties, their use is 
not widespread. Gel encapsulation involves the entrapment of a 
soluble enzyme in the matrix of a synthetic or natural gel. This 
can allow exploitation of the protective effects of the gel micro-
environment, increasing enzymes’ resilience to pH extremes 
and high temperatures.[20,21] The loss of enzymatic activity upon 
gelation or as a result of protein diffusing out of the matrix, 
however, has limited the application of such systems.[21] Protein 
“supercharging”, in which the surface charge of a protein is 
drastically altered, is a proven approach to modify enzyme sur-
face properties.[22] While supercharging has received significant 
attention in cell biology applications,[23–25] its application in pro-
tein purification and the generation of functionalized materials 
has been limited,[26] and it has not been examined in the con-
text of hydrogel immobilization for applications in biocatalysis.
Here, we report on a genetically supercharged bacterial 
phosphotriesterase from Agrobacterium radiobacter, arPTE, 
that can be immobilized on both commercially available syn-
thetic hydrogels and biologically compatible amino acid derived 
hydrogels. arPTE hydrolyses and detoxifies a broad range of 
organophosphorus compounds, including chemical warfare 
agents.[27,28] The increased surface charge of supercharged 
arPTE (R5-arPTE) places it in the top 0.001% of soluble pro-
teins in Escherichia coli by isoelectric point and allows one-step 
purification and ionic immobilization on various anionic hydro-
gels. The resultant immobilized enzyme displays remarkable 
stability in the presence of organic solvents, high substrate 
turnover, enantioselectivity, and longevity. These properties 
have allowed the demonstration of applications in enantioselec-
tive synthesis, detoxification, and the formation of novel bio-
compatible enzyme-hydrogel constructs.
Wild-type (WT)-arPTE was optimized for surface engineering 
through the incorporation of three point mutations previously 
demonstrated to increase its soluble expression: Ala60Val, 
Ala204Gly, and Lys185Arg[29] (Figure 1A). The relative thermo-
stabilities of WT-arPTE and the engineered variant (S3-arPTE) 
were investigated through differential scanning fluorimetry 
(DSF)[30] (Figure S1, Supporting Information). The proteins have 
almost identical melting temperatures (WT = 60.7 ± 0.085 °C, 
S3 = 59.5 ± 0.052 °C), indicating that no major stabilizing or 
destabilizing effects were imparted through the incorporation 
of the three solubilizing mutations, consistent with previous 
work suggesting that the increased soluble expression was not a 
result of stabilization of the holoenzyme.[31]
S3-arPTE was used as the basis for subsequent iterative 
screening of cationizing mutations. A series of target acidic 
amino acids was identified for mutation to positively charged 
amino acids (lysine or arginine), using the Rosetta supercharge 
protocol[22] with the structure of WT-arPTE (2D2J).[32] Absolute 
Surface Area View (ASAView)[33] was then used to calculate the 
solvent accessibility of WT-arPTE residues, since the more exposed 
residues make up a larger proportion of the protein surface. This 
was used to remove amino acids identified by the supercharge 
protocol that were too buried or within the dimer interface. 
Three additional polar amino acids (Ser238, Thr274, and Thr311) 
were added to the list of candidate mutations based on high 
solvent accessibility (Figure 1B). FoldX, which can accurately 
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Figure 1. Engineering cationized arPTE. a) Positions of solubilizing mutations (K185R, A80V, and A204G) highlighted on WT-arPTE (2D2J).[32] Purple 
spheres represent Co2+. b) SDS–PAGE of WT-arPTE and each variant produced during the iterative engineering process. arPTE is visible at ≈35 kDa. 
c) Positions and identities of solubilizing and final cationizing mutations highlighted on R5-arPTE (5W7H).
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predict the stabilizing effect of point mutations, was then used to 
determine whether arginine or lysine was the least destabilizing 
amino acid mutation to make at each position.[34] The effects 
of the mutations on expression were then tested by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) 
(Table S1, Supporting Information). Those mutations that 
caused substantial loss of soluble expression were excluded, 
while those that did not were combined in a stepwise fashion. 
The final variant, R5-arPTE, comprised Gln148Arg, Gln155Arg, 
Ser238Arg, Glu263Arg, and Asp315Arg (Figure 1C and Table S2, 
Supporting Information). A decrease in soluble expression was 
observed throughout the construction of R5-arPTE. The loss of 
soluble expression upon incorporation of these additional posi-
tively charged residues is consistent with previous work that has 
suggested soluble expression of proteins correlates with a lack of 
positively charged surface,[35] but overexpression remained sub-
stantial (Figure 1D), confirming that the supercharging approach 
can allow high-yield enzyme production.
We then analyzed the effects of these mutations on sta-
bility, activity, structure, and net charge. Differential scanning 
fluorimetry indicated that no direct stabilizing effects were 
imparted by the incorporation of the cationizing mutations 
(R5 = 61.1 ± 0.29 °C) (Figure S1, Supporting Information). 
The kinetic parameters of the purified variants were character-
ized through assays with the substrate paraoxon-ethyl, moni-
toring the formation of p-nitrophenolate. The initial stabilizing 
mutations result in a decrease in activity of an order of magni-
tude, which can be attributed to the well-documented trade-off 
between enzyme stability and activity.[36] Because arPTE is a 
highly dynamic and active enzyme, it is likely that the solubi-
lizing mutations cause subtle changes in the conformational 
sampling to reduce the rate of substrate turnover; the relation-
ship between conformational dynamism and turnover rate has 
been demonstrated previously.[29,37] While these initial solubi-
lizing mutations decrease the catalytic efficiency of the enzyme 
approximately ninefold (which is offset by the twofold increase 
in soluble expression), the cationizing mutations have negli-
gible effects on the activity, relative to S3-arPTE (Table S3, Sup-
porting Information). The overall catalytic efficiency of R5-arPTE 
remained very high (kcat/KM = 3.77 × 106 m−1 s−1). Diffraction-
quality crystals of R5-arPTE were obtained in 0.2 m NaNO3, 
10% polyethylene glycol (PEG) 3350, pH 6.1. The structure of 
R5-arPTE was solved using molecular replacement with the 
structure of WT arPTE (2D2J)[32] (Table S4, Supporting Informa-
tion). Analysis of the R5-arPTE structure revealed that the C-α 
positions were essentially identical to that of the WT structure, 
with an root-mean-square deviation (RSMD) value of 0.76 Å.[38] 
The only region of note was loop 7 (residues 258–272), which is 
already very mobile but adopted a slightly different conforma-
tion than in the WT structure. One of the cationizing mutations, 
Glu263Arg, is located on this loop, and may be responsible for 
differences in C-α position, but is unlikely to be significant, given 
that the activity of R5-arPTE is essentially identical to S3-arPTE. 
Using the empirical structures of WT-arPTE and R5-arPTE, we 
were able to calculate the isoelectric point (pI) of each protein 
using PROPKA, which has been shown to be the most accurate 
computational method for calculation of pKa and pI values, with 
a level of error comparable to the best experimental methods.[39] 
The pI of R5-arPTE was estimated to be 10.01, a marked increase 
from the WT-arPTE pI of ≈6.79 (Figure 2).[40,41]
The Proteome-pI database indicates that of the 4314 known 
proteins in the E. coli (K12) proteome, 146 have an isoelectric 
point greater than 10.[43] Of these 145 proteins, only four have 
been experimentally determined to exist in the cytoplasm, and 
none in the periplasm. The remainder are either membrane-
associated (60), ribosomal (23) or have not been conclusively 
assigned a location in the cell (or are hypothetical proteins) 
(59).[44] This puts R5-arPTE in the top ≈0.001% of soluble 
proteins identified in the E. coli (K12) proteome based on iso-
electric point. Indeed, R5-arPTE could be purified from crude 
E. coli lysate in a single step over carboxymethyl (CM) Ceramic 
HyperD resin (Figure S2, Supporting Information).
Adv. Biosys. 2018, 2, 1700240
Figure 2. Monomer structures and electrostatic surface potentials of WT-arPTE (2D2J)[32] (top) and R5-arPTE (5W7H) (bottom) colored from −2.5 kT e−1 
(red) to +2.5 kT e−1 (blue). Isoelectric points as predicted by PROPKA[42] increase from 6.79 (WT) to 10.01 (R5) as a result of surface engineering.
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To test the catalytic properties of ionically immobilized 
R5-arPTE, we used CM Ceramic HyperD resin, which is a com-
mercially available ceramic-encapsulated hydrogel. The hydrogel 
consists of a hydrophilic polymer containing 250–400 CM acidic 
groups (µEq mL−1), making it a weak cation exchanger. A 600 µL 
column of CM Ceramic HyperD resin has a protein binding 
capacity of 36 mg, although only 1 mg of purified R5-arPTE 
was loaded as the activity of the protein is so high that loss of 
activity could only be determined at lower loadings. Full binding 
was confirmed through the absence of any enzymatic activity in 
the flowthrough after loading. A second identical column was 
packed with resin only for use as an experimental control.
To determine the longevity of R5-arPTE immobilized in the 
hydrogel-resin, both in terms of protein “leaching” from the 
hydrogel and the long-term thermostability/denaturation, the 
substrate turnover by the immobilized enzyme was measured 
over the course of 85 d. Because the rate of hydrolysis of par-
aoxon-ethyl is very high (kcat/KM = 4 × 106 m−1 s−1), any loss of 
activity is difficult to observe, since full substrate turnover is 
possible with only a small amount of active enzyme. Accord-
ingly, we used p-nitrophenyl butyrate, which is promiscuously 
turned over by arPTE at ≈1/1000th the rate of paraoxon-ethyl 
(Table S3, Supporting Information). Hydrolysis could be moni-
tored directly via the formation of p-nitrophenolate, and the con-
centration and flow rate were adjusted such that the initial total 
hydrolysis was ≈70%, meaning that any loss of activity would 
be in a detectable range. Hydrolysis was measured at the same 
flow rate, over the same column, at 2 g L−1 substrate loading, at 
25 intervals over a period of 85 d. This resulted in exposure of 
the immobilized enzyme to over 2 L of buffer (≈3000 column 
volumes with a biocatalyst loading of 0.0005 g L−1) with no evi-
dence of reduced enzymatic activity (Figure 3A). On average, 
67% of the loaded substrate was converted with each injection. 
The increase in activity observed after initial measurements was 
attributed to activation-period inactivation. This phenomenon 
has been observed in immobilization experiments a number 
of times.[45–47] The initial immobilization process can limit 
the conformational dynamism of the immobilized enzyme, 
increasing thermostability but decreasing catalytic activity. After 
being exposed to destabilizing conditions—in this instance, 
prolonged time spent at room temperature—conformation-
ally limited proteins are liberated, resulting in an increase of 
activity, before the steady loss of activity commences.
Having demonstrated that the supercharged protein was effec-
tively irreversibly immobilized and was extremely stable when 
bound to the hydrogel, with no detectable loss of activity over a 
period of 85 d, we then sought to estimate the level of substrate 
throughput that was achievable. From the long-term longevity 
analysis, we observe a turnover number of ≈7000 molsubstrate/
molcatalyst, with no loss of activity. We then set out to investigate 
the destruction of the neurotoxic pesticide paraoxon-ethyl. The 
World Health Organization’s recommended maximum concentra-
tion of parathion (the precursor molecule converted to paraoxon 
in vivo) is only 10 µg L−1,[48] while European Union directives 
limit pesticide concentration in drinking water to 0.1 µg L−1.[49] 
Here, we used concentrations several orders of magnitude higher 
than this, from 2.5 to 0.5 g L−1 in 10% methanol, with a small 
amount of catalyst immobilized on the resin (1.5 mg/600 µL 
resin, or 4.2 × 10−8 mol, which is ≈4% of the maximum loading 
capacity of the column) (Table 1). After several runs to determine 
the optimal conditions, an optimum flow rate and substrate 
loading of 0.5 g L−1 at 1 mL min−1 was identified. With these 
conditions, it was possible to hydrolyze ≈95% of 350 mg par-
aoxon-ethyl passed over the column over 11 h. Across the various 
experiments detailed in Table 1, the column achieved turnover of 
1.07 × 105 molproduct/molcatalyst over the course of ≈17 h.
To investigate the potential application of the ionically 
immobilized supercharged proteins in chiral resolution based 
enantioselective catalysis, the chiral organophosphate methyl 
(p-nitrophenyl) phenyl phosphate (MPP) was synthesized as 
a model substrate (Methods in the Supporting Information). 
While R5-arPTE showed no evidence of enantioselectivity with 
MPP (Figure 3B) previous work has shown that the related 
PTE from Pseudomonas diminuta could be engineered to confer 
enantioselectivity for the S- over the R-enantiomer.[50] Thus, 
we introduced one of the mutations previously observed to 
confer enantioselectivity (Gly60Ala) to R5-arPTE. The reaction 
of G60A-R5 and MPP was monitored spectrophotometrically, 
with the addition of NaOH used to determine the end-point of 
the hydrolysis. The hydrolysis of substrate MPP by G60A-R5 
was observed to plateau at 50% end-point hydrolysis, con-
sistent with an enantioselective enzyme-catalyzed hydrolysis 
of primarily one enantiomer of a racemic mixture (Figure 3B). 
Using the previously described immobilization protocol, 1 mg 
of G60A-R5 was applied to a 600 µL column containing the 
ceramic-encapsulated hydrogel. The enantioselectivity of immo-
bilized G60A-R5 was then investigated using high-performance 
liquid chromatography (HPLC) analysis with chiral stationary 
phases. MPP was injected at flow rates of 2–10 mL min−1 over 
the immobilized G60A-R5, and the flowthrough was analyzed 
by HPLC (Table 2). The flowthrough was determined to contain 
MPP with an enantiomeric excess of >99%. The reaction could 
be carried out on a preparative scale, producing synthetically rel-
evant quantities of enantiomerically enriched R-MPP in 30 min.
The stability of the immobilized R5-arPTE hydrogel in non-
aqueous solvents was investigated. A column was packed and 
loaded with R5-arPTE as described above. The destabilizing 
effects of methanol on enzymes are well established,[51] so this 
solvent was selected to test the stability of the immobilized 
enzyme. Increasing concentrations of methanol were passed 
over the R5-arPTE column, and the hydrolysis of p-nitrophenyl 
butyrate at each concentration measured (Figure 3C). The 
activity of R5-arPTE decreased consistently from 20% to 70% 
methanol, which is not unexpected given the catalytic mecha-
nism is dependent on free water molecules to act as nucleo-
philes. However, activity could be restored by washing the 
column with buffer containing no methanol (Figure 3D). The 
loss of activity was essentially fully reversible in methanol 
concentrations up to 70%, and partially reversible up to 90% 
methanol (≈80% recovery). It was only in 100% methanol that 
significant irreversible loss of activity occurred (<20% recovery) 
(Figure 3D). The reversible loss of activity in methanol is 
likely to be due to the stripping of catalytic water molecules 
by the polar organic solvent, which are then restored by the 
aqueous washes.[52] Exposure to concentrations of 80% meth-
anol and above, however, may have resulted in the stripping 
of structurally important water molecules, resulting in irre-
versible denaturing of the enzyme. The solvent resistance of 
Adv. Biosys. 2018, 2, 1700240
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immobilized R5-arPTE was also tested with a less polar sol-
vent, ethyl acetate. An enzyme-bound column was subjected 
to 10 min of exposure to 100% ethyl acetate at a flow rate of 
5 mL min −1. The column was then flushed with buffer for a 
further 10 min at the same flow rate, before activity was tested 
with p-nitrophenyl butyrate at substrate loading of 2 g L−1. No 
reduction in catalytic activity was observed after exposure to a 
cumulative 100 mL of ethyl acetate (Figure 3E). As a control, 
free R5-arPTE in solution was exposed to ethyl acetate, and 
subsequently extracted from the aqueous fraction after solvent 
partitioning. Almost complete loss of activity was observed after 
only 1 min of contact time, indicating that the ionic adsorption 
of the enzyme onto the encapsulated hydrogel imparts signifi-
cant additional stability to organic solvents (Figure 3F).
While synthetic hydrogels, such as the immobilized CM-based 
hydrogel described above, have value in industry, self-assembled 
peptide hydrogels have been shown to have potential applica-
tions as scaffolds in transplant and new regenerative therapies, 
as they can more closely mimic the environment of the cell via 
the inclusion of bioactive amino acid sequences.[53] Enzymes 
embedded within these materials have been shown to have 
improved stability and retained function over extended time 
periods.[54] This combination of properties is of interest, as it 
could allow precise (therapeutic) delivery of enzymatic activity, 
with the biocompatible hydrogel acting to constrain enzymatic 
activity to the physical location. This has been achieved by con-
trol of the surface chemistry via the peptide sequence. The side 
chains of the peptides are presented at a high density within 
Adv. Biosys. 2018, 2, 1700240
Figure 3. Properties of immobilized R5-arPTE. a) The longevity of immobilized R5-arPTE stored at room temperature, as measured by hydrolysis of 
p-nitrophenyl butyrate injected over the immobilized enzyme. b) Enantioselectivity of arPTE variants R5 and R5-G60A. At 6 min, addition of 5 m NaOH 
fully hydrolyses the substrate. 50% conversion is marked with a dotted line. c) Enzymatic hydrolysis of p-nitrophenyl butyrate in increasing concentra-
tions of MeOH. d) Enzymatic hydrolysis of p-nitrophenyl butyrate after exposure to increasing concentrations of MeOH and restoration to aqueous 
buffer. e) Enzymatic hydrolysis of p-nitrophenyl butyrate after exposure to 100% EtOAc, and subsequent restoration to aqueous buffer. f) Activity of 
R5-arPTE in solution after exposure to and extraction from 100% EtOAc.
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the final assembled structure. This localization of properties 
creates dense regions which enable biomacromolecule inclu-
sion by noncovalent incorporation. As the entire solvent is 
entrapped by the gelation process, all of the payload is incor-
porated within the system, and is dependent on the properties 
of the biomacromolecules and matrix. This presents via supra-
molecular interactions with the self-assembled matrix, such 
as hydrophobic,[55] steric,[56] and electrostatic interactions.[57] 
Previous studies have demonstrated the effects of electrostatic 
interactions on the rates of protein diffusion out of hydrogels, 
specifically showing that proteins with the opposite net charge 
of the hydrogel matrix in which they are encapsulated have a 
lower rate of diffusion.[58] With this in mind, we modified our 
previously described hydrogel,[57] which is comprised of Fmoc-
DIKVAV (DX) and has been shown to be biocompatible and to 
self-assemble at physiological pH, to Fmoc-DIKVAVD (DXD), 
which includes aspartic acid at the C-terminus to create a com-
plementary anionic matrix for the cationic enzyme. Samples of 
DX and DXD hydrogels were prepared by solid phase peptide 
synthesis. Solutions of R5-arPTE were added to the liquid 
phase gels to yield a final concentration of 1 mg (protein) mL 
(hydrogel)−1. The hydrogels were allowed to set, washed with 
phosphate buffered saline (PBS) to remove unbound enzyme, 
and tested for activity with paraoxon-ethyl. The structures of 
the hydrogels were not greatly perturbed by the addition of the 
supercharged protein, as estimated from transmission electron 
microscopy (TEM) and Fourier transform infrared spectroscopy 
(FTIR) (Figure 4A–E). Solutions of 200 × 10−3 m paraoxon-ethyl 
were applied to the surfaces of the DX: R5 and DXD: R5 gels, 
allowed to incubate at 25 °C with gentle shaking for 5 min, 
and then extracted for spectrophotometric analysis. The gels 
were then washed with PBS to remove excess substrate. This 
process was repeated five times. The neutral hydrogel DX: 
R5 complex showed a steady decrease in hydrolytic activity 
over the five rounds of washing and substrate addition, con-
sistent with leaching of R5-arPTE from the hydrogel, whereas 
DXD: R5 retained constant activity throughout the experiment 
(Figure 4F). This is consistent with R5-arPTE and DXD forming 
Adv. Biosys. 2018, 2, 1700240
Table 2. Kinetic resolution of (±)-MPP using R5-G60A in flow.
Flow rate [mL min−1] t [min] Yielda) [%] e.r.b)
2 10 – >99:1
5 10 – >99:1
10 10 – >99:1
10 30 40 >99:1
a)Isolated yield following column chromatography; b)e.r. determined by HPLC on the RegisCell chiral stationary phase from Regis technologies.
Table 1. Destruction of paraoxon-ethyl using R5-arPTE in flow.
Run Substrate loading [g L−1] Flow rate [mL min−1] Mass paraoxon [mg] Time [min] Conversiona) [%]
1 1.25 5 375 60 67
2 2.5 2.5 375 60 76
3 2.5 1 375 150 86
4 1 1 50 50 91
5 0.5 1 350 700 95
Total 0.5–2.5 1–5 1525 1020 81
Catalyst loading [mol %] 0.0008
Turnover [molsubstrate/
molcatalyst]
1.07 × 105
a)Determined by 1H NMR of the crude residue after extraction with Et2O.
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a strong ionic interaction, resulting in immobilization of the 
enzyme in the hydrogel under neutral conditions.
For the application of biocatalysts in industrial pro-
cesses, ensuring enzymes can be produced and purified 
quickly and at low cost is vital. The supercharged arPTE 
variant, R5-arPTE, presented in this work was isolated in 
high purity over a single cation exchange column step using 
robust hydrogel-ceramic beads that can tolerate high pres-
sure and are reusable. The same hydrogel-ceramic resin has 
been demonstrated here to act as a versatile immobilization 
matrix for R5-arPTE. Significantly, this represents an efficient 
industrial biocatalysis platform utilizing a single-step process 
from crude E. coli lysate to pure, immobilized, catalytically 
active protein. A further benefit of ionic immobilization is 
the potential for rapid recycling of the resin when enzymatic 
activity eventually deteriorates. R5-arPTE can be stripped 
from the column with high salt buffer (2 m NaCl), allowing 
the resin to be recharged with fresh enzyme. The simplicity 
and flexibility that ionic immobilization allows cannot be 
achieved with covalent crosslinking to media.[59] Additionally, 
in contrast to previous examples of ionic adsorption methods, 
the immobilization and desorption processes are rapid, 
are essentially irreversible under normal conditions, do not 
require prior purification or modification of the enzyme and 
do not require long incubation periods.[60,61]
The immobilized R5-arPTE system could find application 
in bioremediation, particularly in agricultural settings wherein 
pesticides applied to crops can leach into groundwater. One 
of the advantages of continuous-flow chemistry is its ability to 
scale-up efficiently.[62] Thus, the encapsulated hydrogel system 
could be readily scaled up and incorporated into waste–water 
drainage systems in these settings; the ceramic-encapsulated 
hydrogels are resistant to high flow rates and pressures, and 
after depletion of enzymatic activity, the material can be 
stripped with an innocuous NaCl solution and recharged with 
fresh enzyme.
Adv. Biosys. 2018, 2, 1700240
Figure 4. Hydrogel-enzyme constructs and their properties. TEM of a) DX hydrogel, b) DX: R5 construct, c) DXD hydrogel, d) DXD: R5 construct, 
showing that the nanofibrous morphology is largely unaffected by the addition of the enzyme. e) FTIR characterization of DX and DXD hydrogels 
imbued with R5-arPTE, showing consistent β-sheet formation, a further indication that the structural assembly is not affected by the enzyme addition. 
f) Addition of paraoxon-ethyl to the surface of DX and DXD gels imbued with R5-arPTE verifies catalytic activity of the constructs. DX: R5 shows a 
statistically significant decrease in catalytic activity over the course of the experiment, as determined by unpaired student’s t-test (p = 0.0006) while 
DXD: R5 does not (p = 0.112).
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Immobilized R5-arPTE maintained significant hydrolytic 
activity, even in the presence of substantial methanol concen-
trations, and could recover 100% of its catalytic activity after 
exposure to ethyl acetate (in comparison, the free enzyme is 
irreversibly denatured). These observations suggest that the ani-
onic hydrogel microenvironment stabilizes the natively folded 
state of the cationic protein. Polar solvents have been previously 
demonstrated to “strip” catalytic and structurally important 
water molecules from enzymes.[52] In the hydrogel, reduction 
in the polarity of the solvent will increase the strength of the 
ionic bonds between the surface of the protein and the hydrogel 
matrix, effectively stabilizing the structure and preventing 
structural rearrangement upon unfolding that could result 
in hydrophobic surfaces interacting, which normally leads to 
misfolding and aggregation. Indeed, tight interaction between 
the charged surface and the hydrogel may enhance any local 
refolding that might occur. Ionic immobilization of super-
charged proteins could therefore prove useful in flow chemistry 
applications where enzymes are required to function in organic 
solvents, such as in the acylation of alcohols by lipases.[63]
Catalysts, including enzymes, have found widespread appli-
cation in synthetic chemistry for the preparation of enantiopure 
compounds. The value of immobilized catalysts is particularly 
apparent in continuous-flow reactors, which are becoming 
more advanced and accessible. In flow chemistry applications, 
chemical transformations utilizing the specificity and selectivity 
of biocatalysts ideally require solvent-resistant components that 
can be readily stripped and recycled. The simplicity, durability, 
and reusability of supercharged enzyme: hydrogel matrices as 
described here could substantially reduce the costs and enhance 
the versatility of such components.
Finally, the nanostructured hydrogels formed by Fmoc-
self assembling peptides have recently gained interest for the 
potential in regenerative medicine applications. The flexibility 
afforded by these systems is exemplified by their deploy-
ment in the brain where they interface with the surrounding 
parenchyma, have no adverse effect on the immune system, 
and do not impede cell migration or growth. While self-
assembling organophosphate hydrolase gels have been previ-
ously described,[64] the flexibility afforded by a hybrid enzyme: 
hydrogel material is distinct; ionic entrapment in designer 
hydrogels could be readily generalized to any soluble enzyme, 
and both enzyme and gel properties could be tuned for specific 
applications. Further, the biocompatibility of enzyme-impreg-
nated Fmoc complexes broadens the scope of potential medical 
applications of such materials. We anticipate that the inclusion 
of further functionality to such hydrogels, via supercharged 
proteins as presented here, could extend their uses by confer-
ring catalytic activity, delivering bound ligands, or including 
components to promote the formation of protein: protein com-
plexes at the site of transplant.
In this study, we have demonstrated robust ionic immobili-
zation of an engineered, cationically supercharged, arPTE onto 
anionic hydrogels, resulting in a system capable of detoxifying 
organophosphates and catalyzing enantioselective reactions in 
flow. The substantial catalytic lifespan of the R5-arPTE-hydrogel 
system, both in terms of prolonged use and extended storage 
at room temperature, has been demonstrated. The cationic 
surface of R5-arPTE allows a simple ion exchange purification 
protocol, which could be readily scaled up for industrial appli-
cation of the enzyme, and the rapid immobilization on and des-
orption from the hydrogel results in an easily recyclable system, 
where degraded enzyme can be rapidly stripped from the gel 
and replaced with fresh protein. The flexibility and longevity of 
this system addresses some of the main drawbacks of current 
immobilization techniques; the high costs associated with puri-
fication of biocatalysts, the harsh conditions required for cova-
lent attachment, and the propensity for ionically immobilized 
proteins to leach from media with prolonged use. The advances 
demonstrated above provide insight into potential application 
of biocatalysis in industry, synthesis, and bioremediation.
Experimental Section
Site Directed Mutagenesis and Expression Tests: The arPTE gene was 
cloned into the pETMSCI expression vector between the Nde1 and 
EcoR1 restriction sites.[65] Mutants were constructed by the Gibson 
Assembly method.[66] Fragments containing the desired point mutation 
were generated using a pair of mutagenic QuikChange primers and 
a pair of gene-specific primers. pETMSCI vector was digested with 
Nde1 and EcoR1. Fragments and digested vector were purified via gel 
excision, then combined with a Gibson Assembly aliquot. The product 
of the Gibson reaction was transformed into electrocompetent E. coli 
Top 10 cells, and the cells plated on lysogeny broth (LB) agar with 
amp (100 µg mL−1 ampicillin) and incubated overnight. Colonies were 
selected, and colony polymerase chain reaction (PCR) performed with 
T7 forward and reverse primers. PCR product was sequenced to verify 
incorporation of the desired mutations.
Soluble expression of each arPTE variant was tested under consistent 
growth conditions. arPTE variant plasmids were transformed into 
electrocompetent E. coli BL21(DE3) cells, and the cells plated on LB agar 
with amp (100 µg mL−1 ampicillin) and incubated overnight. Colonies 
were selected and used to inoculate small-scale (10 mL) LB cultures, all 
supplemented with amp (100 µg mL−1 ampicillin) and 100 × 10−6 m CoCl2. 
Small-scale cultures were incubated overnight at 30 °C with shaking 
at 200 rpm. To quantify the soluble protein expression in each set of 
conditions, 1 mL of cells was pelleted, resuspended in lysis buffer (Buffer B: 
50 × 10−3 m (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), 
100 × 10−6 m ZnCl2, 1.5 m NaCl, pH 8.0) with 10% v/v BugBuster (Novagen) 
and shaken for 1 h. The lysate was centrifuged at 4000 × g for 10 min and 
both the supernatant and insoluble pellet were analyzed by SDS–PAGE.
Analysis of soluble expression was performed using ImageJ.[67] An 
internal standard against which arPTE expression could be compared was 
selected. This ensured that variability caused by heterogeneous loading 
of samples would not affect perceived soluble expression, and allowed 
for expression to be compared across multiple SDS–PAGE experiments.
Preparative Scale Enzyme Expression and Purification: Electrocompetent 
E. coli BL21(DE3) cells were transformed with arPTE mutant plasmids 
by electroporation. Transformants were plated on LB agar with amp 
(100 µg mL−1 ampicillin) and incubated overnight. Colonies were 
grown in LB medium supplemented with 100 µg mL−1 ampicillin for 
8 h. These cultures were transferred to 1 L terrific broth (TB) medium 
supplemented with 100 µg mL−1 ampicillin and 100 × 10−6 m CoCl2, and 
incubated at 30 °C with shaking overnight. arPTE variants R4 and R5 
were grown in large scale TB cultures supplemented with 10 g L−1 NaCl. 
Cells were pelleted by centrifugation at 4000 × g for 15 min at 4 °C.
All enzymes in this study were purified through ion exchange 
chromatography.
WT, S1, S2, S3, R1, R2, R3: Pelleted cells were resuspended in 
Buffer A (50 × 10−3 m HEPES, 100 × 10−6 m ZnCl2, pH 8.0) and lyzed 
through sonication. Lysate was centrifuged at 26 200 × g for 60 min at 
4 °C to remove cell debris. The resulting supernatant was loaded onto 
a Fractogel diethylaminoethyl (DEAE) anion exchange column (Merck), 
equilibrated with Buffer A. arPTE was collected in the flowthrough after 
Adv. Biosys. 2018, 2, 1700240
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elution with Buffer A. Fractions were analyzed with SDS–PAGE. Purity of 
combined fractions was determined to be between 90% and 95%.
R4, R5: Pelleted cells were resuspended in Buffer B (50 × 10−3 m HEPES, 
1.5 m NaCl, 100 × 10−6 m ZnCl2, pH 8.0) and lyzed through sonication. 
Lysate was centrifuged at 26 200 × g for 30 min at 4 °C to remove cell 
debris, and the clarified lysate was subjected to a heat purification 
step. The lysate was suspended in a water-bath heated to 60 °C for 
15 min, and then centrifuged at 26 200 × g for 30 min at 4 °C to pellet 
precipitated material. The resulting supernatant was diluted tenfold with 
Buffer C (50 × 10−3 m HEPES, 100 × 10−6 m ZnCl2, pH 6.5) and loaded 
onto a column containing CM Ceramic HyperD resin (Pall LifeSciences). 
Unbound protein was washed away with Buffer C, and arPTE eluted with 
an increasing concentration of Buffer D (50 × 10−3 m HEPES, 100 × 10−6 m 
ZnCl2, 1.5 m NaCl, pH 7.0). Fractions were analyzed with SDS–PAGE. Pure 
fractions were pooled and purity was determined to be greater than 95%.
Enzyme Kinetics: Kinetic assays of arPTE variants were carried 
out according to a previously published protocol.[68] In brief, kinetic 
constants for the hydrolysis of paraoxon-ethyl and p-nitrophenyl butyrate 
were determined by monitoring the production of p-nitrophenolate at 
405 nm (ε405 = 17 700 m−1 cm−1) at room temperature. Reactions were 
performed in 20 × 10−3 m Tris (pH 8.5), 100 × 10−3 m NaCl, 100 × 10−6 m 
ZnCl2, and 1 mg mL−1 bovine serum albumin. All kcat and KM values 
were determined by fitting initial velocity data to the Michaelis–
Menten equation. All assays were performed in duplicate, and MeOH 
concentration was kept below 2.5% total reaction volume.
Structural Determination: Purified R5-arPTE was concentrated to 
≈5 mg mL−1 in 20 × 10−3 m HEPES, 50 × 10−3 m NaCl, 100 µL ZnCl2. Screens 
were optimized by hanging-drop vapor diffusion at 18 °C. Drops consisting 
of 4 µL of reservoir and 2 µL of protein were equilibrated over a 500 µL 
reservoir in Crystalgen pregreased 24-well plates. Conditions were screened 
between 100 × 10−3 m sodium nitrate (pH 6.1–6.7), distilled deionized 
water and 4 – 20% (w/v) PEG 3350 g mol−1. Crystals were observed after 
24 h of growth, with the largest crystals growing in 9% PEG 3350, pH 6.1.
For data collection, crystals were coated in cryobuffer (100 × 10−3 m 
sodium nitrate, pH 6.1, 40% PEG 3350) and cooled to 100 K in a stream 
of nitrogen gas. Diffraction data were collected at the Australian 
Synchrotron (MX2 beamline) at a wavelength of 0.9537 Å. X-ray diffraction 
data were indexed and integrated using X-ray detector software (XDS)[69] 
and merged using AIMLESS,[70] within the CCP4 program suite. The 
structure was solved by molecular replacement (MolRep)[71] using WT 
arPTE structure (2D2J).[32] Refinement was performed using PHENIX,[72] 
and manual rebuilding was performed using Coot.[73]
Immobilization of R5-arPTE: A small volume column (0.667 mL) 
was packed with CM Ceramic HyperD resin (Pall LifeSciences) and 
equilibrated with 20 column volumes of Buffer D (50 × 10−3 m HEPES, 
100 × 10−6 m ZnCl2, 1.5 m NaCl, pH 7.0), followed by 20 column volumes 
of Buffer C (50 × 10−3 m HEPES, 100 × 10−6 m ZnCl2, pH 6.5). For activity 
tests, 1 mg of purified R5-arPTE was loaded in Buffer C. The successful 
immobilization of R5-arPTE was verified by collecting the flowthrough 
from the loading step and observing UV absorbance at 280 nm. No 
evidence of protein was observed in the flowthrough. The “R5-arPTE 
column” was stored at room temperature in 50 × 10−3 m HEPES, 
100 × 10−6 m ZnCl2, pH 8.
Tests of Immobilized R5-arPTE Activity: To test the activity, longevity, 
and solvent stability of immobilized R5-arPTE, a flow-assay protocol 
was developed. In each case, 100 µL of 100 × 10−3 m p-nitrophenyl 
butyrate in MeOH was injected over the R5-arPTE column at a flow 
rate of 5 mL min−1, and the concentration of p-nitrophenolate in 
20 mL of flowthrough was determined spectrophotometrically. 100 µL 
of 5 m NaOH was added to 1 mL of this flowthrough to determine 
absorbance for 100% hydrolysis. This provided an internal standard for 
measurements carried out over the course of 85 d. An “empty” column, 
containing CM Ceramic HyperD resin (Pall LifeSciences) and no 
enzyme, was used to establish background hydrolysis of the substrate 
under identical reaction conditions. Stability of the immobilized 
R5-arPTE in methanol was determined by carrying out the standard 
flow-assay protocol in increasing concentrations of methanol in flow 
buffer (50 × 10−3 m HEPES, 100 × 10−6 m ZnCl2, pH 8). Due to the 
limited miscibility of water in ethyl acetate, stability was tested only after 
exposure to 100% ethyl acetate rather than to increasing concentrations. 
50 mL of ethyl acetate was pumped over the R5-arPTE column at 
5 mL min−1, followed by 50 mL of flow buffer. Hydrolysis of substrate 
was then measured using the injection protocol described above. This 
experiment was performed over two separate washes with ethyl acetate, 
and hydrolysis measurements were taken after washes with 50 and 
100 mL of flow buffer. MeOH flow-assay measurements were made in 
triplicate. All other flow-assay measurements were made in duplicate.
Synthesis of Paraoxon-Ethyl: To a solution of p-nitrophenol (4.2 g, 
30 mmol) and potassium carbonate (4.2 g, 30 mmol) in acetone was 
added diethyl chlorophosphate (4.8 mL, 33 mmol) dropwise, and the 
reaction allowed to stir overnight. After this time, the solution was filtered 
and concentrated to yield the paraoxon as a pale yellow oil (6.4 g, 77%). 
1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 9.2 Hz, 2H), 7.37 (dd, 
J = 9.2, 0.8 Hz, 2H), 4.30–4.19 (m, 4H), 1.37 (t, J = 7.2, 3H), 1.33 
(t, J = 7.2, 3H); 13C NMR (101 MHz, CDCl3) δ 155.7 (d, J = 6.3 Hz), 
144.8, 125.8, 120.7 (d, J = 5.4 Hz), 65.3 (d, J = 6.3 Hz), 16.2 
(d, J = 6.6 Hz); 31P NMR (162 MHz, CDCl3) δ −7.11; IR νmax (cm−1) 
2986, 1592, 1522, 1491, 1346, 1225, 1020 (br), 921.
Synthesis of MPP: To a solution of methyl phosphodichloridate (1.4 g, 
9.5 mmol) and phenol (0.73 g, 9.5 mmol) in dichloromethane (40 mL) 
at 0 °C was added triethylamine (0.959 g, 9.5 mmol) dropwise, and the 
reaction allowed to warm to room temperature overnight. After this time, 
the reaction was cooled to 0 °C, and p-nitrophenol (1.16 g, 9.5 mmol) and 
triethylamine (0.959 g, 9.5 mmol) were added. The reaction was again 
allowed to warm to room temperature overnight. The solvent was then 
removed under reduced pressure, and the crude residue diluted with 
Et2O. After washing with dilute NaHCO3, the organic later was dried with 
MgSO4, filtered, concentrated under reduced pressure, and the residue 
purified by column chromatography (1:9 → 1:1, v/v EtOAc: hexanes) to 
afford MPP as a brown oil (1.04 g, 34% yield). Rf 0.49 (1:1, v/v EtOAc: 
hexanes); HPLC RegisCell L40, λ = 254 nm, hexane: iPrOH 95:5, flow 
rate 1 mL min−1, Rt 20.93 and 35.43 min; 1H NMR (400 MHz, CDCl3) 
δ 8.25 (dd, J = 9.6, 0.8 Hz, 2H), 7.41–7.34 (m, 4H), 7.26–7.19 (m, 3H), 
4.01 (d, J = 11.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 155.2(2) 
(d, J = 0.6 Hz), 150.2(3) (d, J = 0.8 Hz), 145.2, 130.2 (d, J = 0.5 Hz), 
126.0 (d, J = 1.1 Hz), 125.9, 120.8 (d, J = 5.4 Hz), 120.0 (d, J = 4.8 Hz), 
56.1 (d, J = 6.5 Hz); 31P NMR (162 MHz, CDCl3) δ −11.65; IR νmax 
(cm−1) 3115, 3081, 1590, 1519, 1487, 1346, 1187, 932 (br).
Enantioselectivity Assays: To determine if arPTE variants R5 and 
G60A-R5 resolved racemic MPP, enzyme reactions were monitored using 
a Cary 60 UV–vis spectrophotometer. 800 µL of 80 × 10−6 m MPP in assay 
buffer (20 × 10−3 m Tris (pH 8.5), 100 × 10−3 m NaCl, 100 × 10−6 m ZnCl2, 
and 1 mg mL−1 bovine serum albumin) was added to a 1 mL plastic 
cuvette, and baseline absorbance at 405 nm was established before 
the addition of 200 µL of enzyme solution to a final concentration of 
40 × 10−9 m. Thorough mixing ensured a homogenous reaction mixture. 
Absorbance was monitored for ≈6 min, or until an obvious plateau was 
observed, suggesting the reaction had reached completion. 100 µL 
of 5 m NaOH was then added to the cuvette, mixed thoroughly, and 
subsequent absorbance monitored. Dilution of the reaction mixture 
upon addition of NaOH was factored into calculations.
Kinetic Resolution of MPP Under Continuous-Flow: Continuous-flow 
experiments were performed using a Vapourtec E-series easy-Medchem 
integrated flow chemistry system. The flow system was set up with 
reservoirs containing flow buffer and MPP (5 × 10−3 m in MeOH). The 
outlet of the column discharged into a beaker of Et2O. Buffer was passed 
over the column at 0.9 mL min−1 and MPP at 0.1 mL min−1, such that 
the column solvent was 1:9 buffer: MeOH. This ratio was maintained 
when flow rates were varied. Reaction time was measured from first 
observance of p-nitrophenolate at the column outlet. After the reaction 
time, the collected buffer/Et2O was extracted with Et2O until the yellow 
p-nitrophenolate was not visible in the aqueous layer. The combined 
organics were dried with Na2SO4, filtered, and concentrated under 
reduced pressure. The crude residue was analyzed by 1H NMR and 
HPLC on a chiral stationary phase (RegisCell chiral stationary phase 
(4.6 mm × 25 cm) column from Regis).
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Destruction of Paraoxon-Ethyl in Flow: The flow system was set up 
with reservoirs containing flow buffer and paraoxon-ethyl (0.5–2.5 g L−1 
in MeOH). The outlet of the column discharged into a beaker of Et2O. 
Buffer was passed over the column at 0.9 mL min−1 and paraoxon-ethyl 
at 0.1 mL min−1, such that the column solvent was 1:9 buffer: MeOH. 
This ratio was maintained when flow rates were varied. Reaction time 
was measured from first observance of p-nitrophenolate at the column 
outlet. After the reaction time (see Table 1), the collected buffer/Et2O 
was extracted with Et2O until the yellow p-nitrophenolate was not visible 
in the aqueous layer. The combined organics were dried with Na2SO4, 
filtered, and concentrated under reduced pressure. The crude residue 
was analyzed by 1H NMR.
Differential Scanning Fluorimetry: Determination of Tm for WT-arPTE, 
S3-arPTE, and R5-arPTE was carried out by DSF with SYPRO Orange 
(Sigma) as the reporter dye. Assay solutions consisted of 10 × 10−6 m 
protein and a final concentration of 1 × SYPRO Orange, and were made 
up to a total volume of 30 µL with 20 × 10−3 m HEPES, 50 × 10−3 m NaCl, 
100 µL ZnCl2, pH 8. Temperature ramping was performed using a 7900HT 
Fast RealTime PCR (ThermoFisher, Applied Biosystems), and fluorescence 
data were collected (Excitation = 490 nm, Emission = 575 nm), before 
analysis with the SDS 2.4 software package (Applied Biosystems). DSF 
thermal shift assays were performed in triplicate.
Fmoc-Self-Assembling Peptide (SAP) Hydrogel Gelation: Fmoc-SAPs 
were engineered by solid phase peptide synthesis using a custom made 
rotating glass reaction vessel as previously reported.[74] Fmoc protected 
amino acids, hydroxybenzotriazole (HOBt), O-benzotriazole-N,N,N′,N′-
tetramethyl-uronium-hexa-fuoro-phosphate and Wang based resins were 
purchased from Pepmic (China). All other chemicals were purchased 
from Sigma-Aldrich. Fmoc-SAPs hydrogels were prepared at 15 mg mL−1. 
Briefly, 10 mg of peptide was dissolved into 200 µL of deionized water 
with 100 µL 0.5 m sodium hydroxide. Then 0.1 m of hydrochloric acid 
was slowly added with continuously vortexing and the pH of peptide 
solution was monitored until it reached physiological relevant pH. 
Typically, 300 µL of 0.1 m HCl was used to achieve this. Once the gel 
formed with the optimal pH attained, PBS was added to bring the gel up 
into 15 mg mL−1 concentration. The pH of the gels was measured by an 
Oaktron pH 700 micro pH electrode (Thermo Scientific).
FTIR Spectroscopy of Fmoc-SAP Hydrogels: FTIR spectra were collected 
by using an Alpha Platinum Platinum Attenuated total reflectance FTIR 
(Bruker Optics). Approximately 30 µL of peptide hydrogel (15 mg mL−1) 
was placed on the single reflection diamond and allowed to sit for 
10 min evaporating the solvent, which enables minimal contribution 
from the solvent to the spectra. Absorbance scans of the amide I region 
(1550–1750 cm−1) were obtained for each peptide, and the background 
buffer scan subtracted.
TEM of Fmoc-self-assembling peptide (SAP) Hydrogels: TEM was 
performed on a Hitachi H7100FA electron microscope using a 100 kV beam 
with a LaB6 cathode. Formvar coated copper grids were glow-discharged for 
30 s at 15 mA. Hydrogel samples were negatively stained with 0.75% uranyl 
formate (UF): after glow discharge the grids were gently immersed in the 
sample for 30 s, briefly immersed in two consecutive drops of deionized 
water, before two drops of the UF negative stain solution was added for 
20 s. The grids were gently blotted dry between immersions.
Determination of R5-arPTE Activity in Biocompatible Hydrogels: 
R5-arPTE was incorporated into DX and DXD gel samples (0.66 mL gel), 
to a final concentration of 1 mg (enzyme) mL (gel)−1. PBS was 
incorporated into identical DX and DXD samples to act as experimental 
controls. After gelation, the surfaces of DX + R5 and DXD + R5 were 
washed with 5 mL of PBS to remove unbound enzyme. Solutions 
of paraoxon-ethyl (200 × 10−3 m) were added to the surfaces of the 
enzyme-gel constructs, and the constructs were shaken gently at room 
temperature for 5 min. After the incubation period, solutions were 
removed from the surfaces of the gels and their absorbance at 405 nm 
was measured. The gels were washed with PBS to remove excess 
substrate (5 min incubation with PBS), and the addition of substrate 
was repeated. This process was repeated a total of five times.
Statistical Analysis: Wherever error is presented in figures, it is in the 
format mean ± SE. SE (standard error) is calculated using
= √SE
S
n  (1)
where S is standard deviation from the mean and n is the sample size. 
Unless otherwise stated in the text, n = 2.
For enzyme kinetics, kcat and KM values were derived by fitting 
collected data to the Michaelis–Menten equation
( )
[ ]
[ ]= +0
max
M
V
V S
K S
 (2)
where V0 is initial velocity, Vmax is maximum velocity, and [S] is substrate 
concentration.
Determination of statistical significance was carried out using an 
unpaired student’s t-test.
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